Clinical Outcomes of Proton Beam Re-Irradiation for Recurrent Gliomas

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2019.06.2234
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

2012English

Clinical Outcomes and Toxicity of Proton Beam Therapy for Advanced Cholangiocarcinoma

Radiation Oncology
Nuclear MedicineRadiologyImagingOncology
2014English

Treatment Outcomes of Re-Irradiation in Locoregionally Recurrent Rectal Cancer and Clinical Significance of Proper Patient Selection

Frontiers in Oncology
Cancer ResearchOncology
2019English

Salvage Fractionated Stereotactic Re-Irradiation (FSRT) for Patients With Recurrent High Grade Gliomas Progressed After Bevacizumab Treatment

JHN Journal
2018English

Proton Beam Reirradiation for Locally Recurrent Pancreatic Adenocarcinoma

Journal of Gastrointestinal Oncology
OncologyGastroenterology
2017English

Hyperfractionated Re-Irradiation for Recurrent Head and Neck Cancer

Japanese jornal of Head and Neck Cancer
2001English

Safety and Efficacy of Bevacizumab With Hypofractionated Stereotactic Irradiation for Recurrent Malignant Gliomas

International Journal of Radiation Oncology Biology Physics
OncologyRadiologyCancer ResearchRadiationNuclear MedicineImaging
2009English

Recurrent Malignant Gliomas

Seminars in Radiation Oncology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2014English

Re-Irradiation of Ntracranial Tumors With Active Beam Scanning Protons

Siberian Journal of Oncology
Cancer ResearchOncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy